Work

152: Long Term Remission in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Patients After Allogeneic Myeloablative Hematopoietic Cell Transplantation (HCT) Using Matched Related Donors: The 20 Year Experience at Stanford University and City of Hope National Medical Center

Year: 2008

Type: article

Abstract: Tabled 110-Year OutcomesDisease StatusnFolllowup (range)OSEFSRelapseNRMCR14975 months (14–180)54%48%28%31%>CR130127 months (16–245)29%26%41%54%p value0.010.020.280.03 Open table in a new tab

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2007.12.161

Authors: G.G. Laport, J.C. Alvarnas, J.M. Palmer, D.S. Snyder, M.L. Slovak, A.M. Cherry, R.S. Negrin, K.G. Blume, S.J. Forman

Institutions: Stanford Medicine, City Of Hope National Medical Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W1995418977

FWCI:

Cites:

Cited by:

Related to: 10